These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 18296816)
1. Model for end-stage liver disease and outcome of portosystemic encephalopathy. Khurram M; Ahmed K; Arshad MM; Khar HB; Hasan Z J Postgrad Med; 2008; 54(1):61-2. PubMed ID: 18296816 [No Abstract] [Full Text] [Related]
2. [Diagnosis of acute liver failure]. Pott G; Krummenerl T; Lohmann J; Gerlach U Dtsch Med Wochenschr; 1983 Sep; 108(35):1324-7. PubMed ID: 6349959 [No Abstract] [Full Text] [Related]
3. Predictors of mortality in hepatic encephalopathy in acute and chronic liver disease: a preliminary observation. Udayakumar N; Subramaniam K; Umashankar L; Verghese J; Jayanthi V J Clin Gastroenterol; 2007; 41(10):922-6. PubMed ID: 18090162 [TBL] [Abstract][Full Text] [Related]
7. Relationship of the model for end-stage liver disease (MELD) scale to hepatic encephalopathy, as defined by electroencephalography and neuropsychometric testing, and ascites. Yoo HY; Edwin D; Thuluvath PJ Am J Gastroenterol; 2003 Jun; 98(6):1395-9. PubMed ID: 12818287 [TBL] [Abstract][Full Text] [Related]
8. Ascites and encephalopathy in chronic liver disease. Hardikar W Indian J Pediatr; 2002 Feb; 69(2):169-73. PubMed ID: 11929034 [TBL] [Abstract][Full Text] [Related]
10. The role of hepatic encephalopathy in the era of MELD. Thornton JG; Mullen KD Liver Transpl; 2007 Oct; 13(10):1364-5. PubMed ID: 17902142 [No Abstract] [Full Text] [Related]
12. Predictors of outcome in children with acute viral hepatitis and coagulopathy. Srivastava A; Yachha SK; Poddar U J Viral Hepat; 2012 Feb; 19(2):e194-201. PubMed ID: 22239519 [TBL] [Abstract][Full Text] [Related]
13. [Comparative effectiveness of different treatment methods of liver failure]. Kutepov DE; Vershinina MG; Pasechnik IN; Sal'nikov PS Khirurgiia (Mosk); 2014; (3):32-6. PubMed ID: 24781068 [TBL] [Abstract][Full Text] [Related]
14. Theory and experience behind the use of coagulation tests in diagnosis and prognosis of liver disease. Koller F Scand J Gastroenterol Suppl; 1973; 19():51-61. PubMed ID: 4515641 [No Abstract] [Full Text] [Related]
16. Value of regional cerebral blood flow in the evaluation of chronic liver disease and subclinical hepatic encephalopathy. Yazgan Y; Narin Y; Demirturk L; Saracoglu M; Ercan M; Akyatan N; Dalkanat N; Ozel AM; Cetin M J Gastroenterol Hepatol; 2003 Oct; 18(10):1162-7. PubMed ID: 12974903 [TBL] [Abstract][Full Text] [Related]
17. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis. Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377 [TBL] [Abstract][Full Text] [Related]
18. Early allograft dysfunction after liver transplantation: a definition and predictors of outcome. National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Deschênes M; Belle SH; Krom RA; Zetterman RK; Lake JR Transplantation; 1998 Aug; 66(3):302-10. PubMed ID: 9721797 [TBL] [Abstract][Full Text] [Related]
19. Discriminative and prognostic signs in acute hepatic coma, treated by exchange transfusions. Demedts M; De Groote J; Vandamme B; Desmet VJ Digestion; 1974; 11(1-2):105-14. PubMed ID: 4452417 [No Abstract] [Full Text] [Related]
20. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease. Said A; Williams J; Holden J; Remington P; Gangnon R; Musat A; Lucey MR J Hepatol; 2004 Jun; 40(6):897-903. PubMed ID: 15158328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]